Biblio
Journal Article
Doorduijn JK, Zijlstra JM, Lugtenburg PJ, Kersten MJosee, Böhmer LH, Minnema MC, MacKenzie MA, Kooij Rvan Marwij, de Jongh E, Snijders TJF, et al. Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial. Br J Haematol. 2020.
Brink M, Meeuwes FO, van der Poel MWM, Kersten MJosé, Wondergem M, Mutsaers PGNJ, Böhmer LH, Woei-A-Jin FJSherida, Visser O, Oostvogels R, et al. Impact of Etoposide and ASCT on Survival Among Patients <65 years With Stage II-IV PTCL; a Population-Based Cohort Study.. Blood. 2022.
Lugtenburg PJ, Zijlstra JM, Doorduijn JK, Böhmer LH, Hoogendoorn M, Berenschot HW, Beeker A, de Graauw NC van der, Schouten HC, Bilgin YM, et al. Rituximab-PECC induction followed by Y-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT: results from a phase II HOVON study. Br J Haematol. 2019.